Real-time financial, economic, and global news with market-focused context and analysis.
Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.
Cadence Design Systems Sr. Vice President Paul Cunningham sold 1,000 shares on February 2, 2026, for $295,090 under a pre-existing Rule 10b5-1 plan. The sale coincides with a recent pullback in the stock and precedes an upcoming earnings report; the company has also announced a new DSP product and a board appointment.
Markets turned cautious after major U.S. technology firms, widely expected to report strong quarters, left some investors exposed heading into earnings season. Alphabet posted robust results after the bell but surprised analysts by announcing capital expenditure guidance of $175 billion to $185 billion for the year, well above Wall Street expectati…
Australian equities closed lower on Thursday with the S&P/ASX 200 falling 0.43% as losses in the Gold, Metals & Mining and Resources sectors pressured the market. A mix of notable winners in wine, retail and wealth management contrasted with heavy declines among uranium, biotech and defense technology names. Commodities and currency moves included …
Russia's ambassador to Cuba, Viktor Coronelli, told a state news agency that Russia has supplied oil to Cuba repeatedly in recent years and expects that pattern to persist. The comments come after U.S. statements about engaging with Cuban leadership and measures aimed at preventing oil shipments to the island, actions that have been linked to risin…
aTyr Pharma CEO Shukla Sanjay sold 3,745 shares on Feb. 4, 2026 to satisfy tax withholding associated with vested restricted stock units, after receiving 10,375 shares on Feb. 3, 2026. The company, with a market capitalization of $86.28 million, is trading slightly below its fair value while reporting that it holds more cash than debt but is rapidl…
Most Asian currencies weakened on Thursday as the U.S. dollar gained ground ahead of European and U.K. central bank meetings. Market jitters from a broader sell-off in global financial markets and a focus on upcoming policy decisions kept risk-sensitive currencies under pressure. The yen was notably soft ahead of Japan’s lower house elections, whil…
Todd Watanabe, President and CEO of Arcutis Biotherapeutics (NASDAQ: ARQT), sold 19,833 shares on February 2, 2026, for $505,709 to satisfy tax withholding tied to restricted stock units. The transaction leaves Watanabe with 721,306 directly held shares and several additional holdings held indirectly through trusts and an LLC. The company has poste…
Rio Tinto is widely expected to request an extension to the UK takeover timetable before the February 5 deadline, sources say, allowing more time to scrutinise early-stage merger discussions with Glencore. Some investors, particularly in Australia, are signalling opposition to any deal that involves a premium or fails to clearly create value, citin…
Toyota Motor is forecast to record a third straight quarterly drop in operating profit for the October-December period, with analysts pointing to rising costs and U.S. tariffs as key headwinds even as global vehicle sales hit a record and hybrid models remain in strong demand. The company’s full-year outlook remains elevated, supported by currency …
UroGen Pharma Ltd's Chief Medical Officer, Mark Schoenberg, sold 7,373 ordinary shares on February 3, 2026, at $19.69 apiece to satisfy withholding tax tied to settled restricted stock units. The company recently reported third-quarter 2025 results that missed consensus on earnings per share and revenue, and no analyst actions or M&A updates have b…
Adaptive Biotechnologies Chief Executive and Chairman Chad M. Robins sold 124,998 shares on February 2, 2026, for about $2.3 million under a Rule 10b5-1 plan. The transaction coincides with a year of notable revenue gains for the company and strategic agreements with Pfizer, though valuation metrics and negative EBITDA highlight ongoing financial c…
Pan American Silver (PAAS) trades like a company priced for perfection while the underlying metals cycle still has room to run. Fundamentals show healthy liquidity and low leverage, but negative free cash flow and elevated valuation metrics require discipline. This trade targets a measured long on a pullback in the mid term (45 trading days) with a…
Director Peter A. Thompson reported the sale of Sionna Therapeutics stock across two days in early February 2026, totaling $1.37 million. The transactions occurred at prices between $44.57 and $44.58 per share. The company has recently drawn contrasting analyst views: Raymond James has raised its price target and kept a Strong Buy, while RBC Capita…
Adaptive Biotechnologies Chief Scientific Officer Harlan S. Robins sold 42,788 shares across February 2 and 3, 2026, realizing approximately $799,104. The transactions were carried out under a Rule 10b5-1 plan and occurred as the company reported significant 2025 revenue gains and announced strategic collaborations and financing activity.
OpenAI is enlarging its technical consulting unit with plans to hire hundreds of staff to help large companies build bespoke AI applications and task-automation agents. The move supports a new enterprise product intended to centralize corporate AI deployments and comes as the company readies a late-2026 initial public offering and increases capital…
Alphabet told investors that its recent AI investments are producing measurable returns across both consumer and enterprise businesses, citing strong engagement with the Gemini 3 model, rapid growth in cloud revenue and a materially higher capex outlook tied to AI computing capacity. The messaging, delivered after the company’s earnings release, sh…
Chief Financial Officer Daniella Beckman sold 10,317 shares of Tango Therapeutics (NASDAQ: TNGX) on February 3, 2026, realizing roughly $126,530. The disposals, reported on a Form 4 with the Securities and Exchange Commission, were executed in two transactions and were disclosed as tax-withholding sales tied to restricted stock unit vesting. The co…
SoftBank Group shares plunged on Thursday after Arm Holdings reported weaker-than-expected licensing revenue for the December quarter. The decline in Arm, coupled with a broader technology sector pullback driven by uncertainty over artificial intelligence, pushed SoftBank down as much as 7% and helped drag the Nikkei 225 lower by 1%.
Christopher S. Ziluca, chief credit officer at Hancock Whitney Corp (HWC), sold 5,227 shares on January 23, 2026, for $68.57 per share, totaling $358,415. After the sale and a domestic-relations transfer, Ziluca directly holds 33,301.4529 shares. The transaction comes amid Hancock Whitney’s fourth-quarter 2025 results that showed a slight earnings-…
Thailand's headline consumer price index declined 0.66% year-on-year in January, marking the 10th straight month of negative annual inflation. The drop outpaced a Reuters poll forecast of a 0.40% decline and remained well under the central bank's 1-3% target. Officials expect headline inflation to stay negative through early spring, while core infl…
Jeffrey P. Klenk, Executive Vice President of Travelers Companies (TRV), sold 16,712 shares on January 23, 2026, for roughly $4.6 million at an average price of $279.7746. On the same day he exercised options to acquire 16,712 shares in two tranches, with exercise prices of $140.85 and $132.58, totaling $2,256,299. The company recently reported ope…
Asian stock markets slid on Thursday after a wave of volatility in global technology shares. Investors pared back positions following a sell-off in U.S. tech stocks, and concern that rapid advances in artificial intelligence could disrupt business models weighed on sentiment. Major indexes from South Korea to Hong Kong retreated from recent record …
MapLight Therapeutics director Robert C. Malenka sold 7,040 shares of the company's Voting Common Stock on February 2-3, 2026, at prices between $18.00 and $18.02 per share, producing proceeds of $126,860. After the transactions, Malenka directly holds 358,233 shares and indirectly holds 31,672 shares via a living trust. The company has reported fa…
Lemonade CEO Daniel A. Schreiber sold 9,108 shares on January 23, 2026, for roughly $902,056 under a pre-arranged Rule 10b5-1 plan. The stock traded at $99.04 at the time - close to its 52-week high - and has since retreated to $74.18. The company faces several near-term events, including an earnings release and the scheduled expiration of warrants…
Sony reported a 22% increase in third-quarter operating profit for October-December, with operating profit of 515 billion yen beating the LSEG analyst average of 469 billion yen. The company raised its full-year operating profit forecast by 8% to 1.54 trillion yen, citing the music business. Market concerns persist about future growth drivers for t…
